453 related articles for article (PubMed ID: 20839968)
1. Bone disease in HIV infection: a practical review and recommendations for HIV care providers.
McComsey GA; Tebas P; Shane E; Yin MT; Overton ET; Huang JS; Aldrovandi GM; Cardoso SW; Santana JL; Brown TT
Clin Infect Dis; 2010 Oct; 51(8):937-46. PubMed ID: 20839968
[TBL] [Abstract][Full Text] [Related]
2. Bone health and human immunodeficiency virus infection.
Schafer JJ; Manlangit K; Squires KE
Pharmacotherapy; 2013 Jun; 33(6):665-82. PubMed ID: 23553497
[TBL] [Abstract][Full Text] [Related]
3. Bone alterations associated with HIV.
Warriner AH; Mugavero M; Overton ET
Curr HIV/AIDS Rep; 2014 Sep; 11(3):233-40. PubMed ID: 25064454
[TBL] [Abstract][Full Text] [Related]
4. Low bone mineral density with tenofovir: does statistically significant mean clinically significant?
Carr A; Hoy J
Clin Infect Dis; 2010 Oct; 51(8):973-5. PubMed ID: 20828303
[No Abstract] [Full Text] [Related]
5. Bone health in children and adolescents with perinatal HIV infection.
Puthanakit T; Siberry GK
J Int AIDS Soc; 2013 Jun; 16(1):18575. PubMed ID: 23782476
[TBL] [Abstract][Full Text] [Related]
6. Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity.
Cotter AG; Powderly WG
Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):501-15. PubMed ID: 21663843
[TBL] [Abstract][Full Text] [Related]
7. HIV infection and bone disease: implications for an aging population.
Cotter AG; Mallon PW
Sex Health; 2011 Dec; 8(4):493-501. PubMed ID: 22127034
[TBL] [Abstract][Full Text] [Related]
8. Bone Density and Fractures in HIV-infected Postmenopausal Women: A Systematic Review.
Cortés YI; Yin MT; Reame NK
J Assoc Nurses AIDS Care; 2015; 26(4):387-98. PubMed ID: 26066693
[TBL] [Abstract][Full Text] [Related]
9. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of screening practices for low bone mass and prevalence of osteoporosis and fractures in people living with human immunodeficiency virus attending a sexual health clinic.
Davidson N; Sowden D
Intern Med J; 2019 Sep; 49(9):1119-1124. PubMed ID: 31081166
[TBL] [Abstract][Full Text] [Related]
11. Bone, fracture and frailty.
Hoy J
Curr Opin HIV AIDS; 2011 Jul; 6(4):309-14. PubMed ID: 21537171
[TBL] [Abstract][Full Text] [Related]
12. Alveolar bone in human immunodeficiency virus infection: is it changed by long-term antiretroviral therapy?
Nittayananta W; Kanjanaprapas A; Arirachakaran P; Pangsomboon K; Sriplung H
Int Dent J; 2017 Apr; 67(2):123-129. PubMed ID: 27864831
[TBL] [Abstract][Full Text] [Related]
13. [Metabolic bone disorders in HIV patients].
Reisfeld S; Chowers M
Harefuah; 2013 Apr; 152(4):238-41, 245. PubMed ID: 23844528
[TBL] [Abstract][Full Text] [Related]
14. HIV and bone disease.
Stone B; Dockrell D; Bowman C; McCloskey E
Arch Biochem Biophys; 2010 Nov; 503(1):66-77. PubMed ID: 20682280
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Stable Bone Mineral Density in HIV-Infected Men Without Risk Factors for Osteoporosis Treated with Antiretroviral Therapy.
Bolland MJ; Horne AM; Briggs SE; Thomas MG; Reid IR; Gamble GD; Grey A
Calcif Tissue Int; 2019 Oct; 105(4):423-429. PubMed ID: 31250043
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density in HIV-infected women taking antiretroviral therapy: a systematic review.
Carvalho EH; Gelenske T; Bandeira F; Albuquerque Mda F
Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):133-42. PubMed ID: 20485901
[TBL] [Abstract][Full Text] [Related]
17. The rate of bone loss slows after 1-2 years of initial antiretroviral therapy: final results of the Strategic Timing of Antiretroviral Therapy (START) bone mineral density substudy.
Carr A; Grund B; Schwartz AV; Avihingsanon A; Badal-Faesen S; Bernadino JI; Estrada V; La Rosa A; Mallon P; Pujari S; White D; Wyman Engen N; Ensrud K; Hoy JF;
HIV Med; 2020 Jan; 21(1):64-70. PubMed ID: 31642586
[TBL] [Abstract][Full Text] [Related]
18. Management of bone mineral density in HIV-infected patients.
Negredo E; Bonjoch A; Clotet B
Expert Opin Pharmacother; 2016; 17(6):845-52. PubMed ID: 26809940
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density changes after 2 years of ARV treatment, compared to naive HIV-1-infected patients not on HAART.
Rey D; Treger M; Sibilia J; Priester M; Bernard-Henry C; Cheneau C; Javier RM
Infect Dis (Lond); 2015 Feb; 47(2):88-95. PubMed ID: 25426996
[TBL] [Abstract][Full Text] [Related]
20. CD4 T cell count is inversely associated with lumbar spine bone mass in HIV-infected men under the age of 50 years.
Kwak MK; Lee EJ; Park JW; Park SY; Kim B-; Kim TH; Suh K; Koh J-; Lee SH; Byun D-
Osteoporos Int; 2019 Jul; 30(7):1501-1510. PubMed ID: 30915506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
